1-20 of 65
Juan Du
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Teclistamab in a large cohort of ~100 Asian patients with triple-class exposed multiple myeloma: Experience from trials and non-trial settings

Free
Tadao Ishida, Jun Ho Yi, Chandramouli Nagarajan, Zhen Cai, Weijun Fu, Shinsuke Iida, Sung-Hoon Jung, Yoshiaki Kuroda, Chang-Ki Min, Ting Niu, Aditi Manjeri, Dok Hyun Yoon, Kazuko Nishikawa, Xiaohong Wang, Yang Song, Hiroshi Yamazaki, Yusuke Izumi, Jianmin Zhuo, Yan Zhu, Juan Du
Journal: Blood
Blood (2025) 146 (Supplement 1): 5815.
https://doi.org/10.1182/blood-2025-5815
Published: 2025
Journal Articles

A dual targeting BCMA and CD19 fastcar-t (GC012F/AZD0120) as first-line therapy for newly diagnosed multiple myeloma

Free
Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Nina Shah, Qi Zhang, Lianjun Shen, Jia Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 258.
https://doi.org/10.1182/blood-2025-258
Published: 2025
Journal Articles

Daratumumab-based therapy for newly diagnosed multiple myeloma patients with renal impairment：a multicenter retrospective study from China

Free
Yingying Ye, Long Chang, Jun Luo, Hua Wang, Chong Wang, Wei WANG, Hui-Han Wang, Qingming Wang, Songfu Jiang, Juan Du, Junqing Xv, Haiping Yang, Xiaoqi Qin, Huang Hongming, Hua Xue, Junbai Fang, Weiwei Tian, He-Bing Zhou, Wen-Rong Huang, Ying Zhao, Jingnan Sun, Ying Sun, Wenming Chen, Hong-Hu Zhu, Jian Li, Wen Gao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7546.
https://doi.org/10.1182/blood-2025-7546
Published: 2025
Journal Articles

Aponermin combined with carfilzomid-pomalidomide-dexamethasone (KPd) in patients with relapsed or refractory multiple myeloma: A prospective, open-label, multicenter study

Free
Jing Chen, Donghua He, Xiaoyan Han, Mingming Zhang, Li Yang, Haimeng Yan, Lai Jin, He Huang, Juan Du, Aijun Liu, Zhen Cai
Journal: Blood
Blood (2025) 146 (Supplement 1): 2276.
https://doi.org/10.1182/blood-2025-2276
Published: 2025
Journal Articles

A first-in-human study of CT0596, an allogeneic CAR T-cell therapy targeting BCMA, in patients with relapsed/refractory multiple myeloma

Free
Juan Du, Lina Jin, Wanting Qiang, Pei Guo, Haiyan He, Xiaoqiang Fan, Xinying Zhao, Daijing Yuan, Yi Luo, Zonghai LI
Journal: Blood
Blood (2025) 146 (Supplement 1): 2296.
https://doi.org/10.1182/blood-2025-2296
Published: 2025
Journal Articles

Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai

Free
Fangfang Yu, Jiahua Niu, Jianmin Yang, Jian Hou, Siguo Hao, Aibin Liang, Hong Xiong, Qi Zhu, Ligen Liu, Jun Shi, Juan Du, Bobin Chen, Rong Wei, Wenli Zhao, Lihua Sun, Yunhua Hou, Rong Tao, Xianmin Song
Journal: Blood
Blood (2024) 144 (Supplement 1): 7818.
https://doi.org/10.1182/blood-2024-199964
Published: 2024
Journal Articles

Autologous B Cell Maturation Antigen (BCMA) and CD19 Dual Targeting Fastcar-T Cells (GC012F/AZD0120) As First-Line Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma Patients

Free
Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Nina Shah, Qi Zhang, Jia Liu, Lihong Weng, Lianjun Shen, Wei Cao
Journal: Blood
Blood (2024) 144 (Supplement 1): 2072.
https://doi.org/10.1182/blood-2024-204774
Published: 2024
Journal Articles

Comparative Effectiveness of Linvoseltamab Versus Current Real-World Standard of Care Therapies in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Treated at IMWG Sites

Free
Shaji Kumar, Sundar Jagannath, Katja C. Weisel, Laura Rosiñol Dachs, Meletios-Athanasios Dimopoulos, David S. Siegel, Jorge Monge, Xavier Leleu, Juan Du, Javier de la Rubia, Jae Hoon Lee, María-Victoria Mateos, Alessandro Gozzetti, Dominik Dytfeld, Enrique M. Ocio, Joan Bladé, Shuji Ozaki, Madhu Nagaraj, Rafla Hassan, Jeannette Green, Glenn S. Kroog, Karen Rodriguez Lorenc, Christian Hampp, Qiufei Ma, Brian G.M. Durie
Journal: Blood
Blood (2024) 144 (Supplement 1): 7039.
https://doi.org/10.1182/blood-2024-210376
Published: 2024
Journal Articles

Pooled Efficacy and Safety of Teclistamab in 217 Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma from 3 Registrational Clinical Studies

Free
Thomas G Martin, María-Victoria Mateos, Niels W.C.J. van de Donk, Zhen Cai, Weijun Fu, Alfred L Garfall, Shinsuke Iida, Yoshiaki Kuroda, Ting Niu, Ajay K. Nooka, Surbhi Sidana, Katherine Chastain, Margaret Doyle, Kazuko Nishikawa, Yang Song, Hiroshi Yamazaki, Jianmin Zhuo, Yan Zhu, Juan Du, Tadao Ishida
Journal: Blood
Blood (2024) 144 (Supplement 1): 3331.
https://doi.org/10.1182/blood-2024-200354
Published: 2024
Journal Articles

Zanubrutinib Combined with R-CHOP in Previously Untreated Non-Germinal Center B-Cell (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) Patients with BCL2 and MYC Protein Co-Expression: A Multicenter, Phase II Study

Free
Jia Jin, Yalan Wang, Xi Wang, Yonghong Tang, Shan Zeng, Juan Du, Junning Cao
Journal: Blood
Blood (2024) 144 (Supplement 1): 3116.
https://doi.org/10.1182/blood-2024-200585
Published: 2024
Journal Articles

GPRC5D-Targeted CAR T-Cell Therapy CT071 for the Treatment of Refractory/Relapsed Multiple Myeloma

Free
Juan Du, Lina Jin, Sinan Gu, Jing Lu, Haiyan He, Qianqi Ruan, Wanting Qiang, Xiaoqiang Fan, Jin Liu, Xingxing Meng, Nishanthan Rajakumaraswamy, Deng Chen, Zonghai Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 3451.
https://doi.org/10.1182/blood-2024-204790
Published: 2024
Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Free
Chuanying Geng, Jing Lu, Xiaozhe Li, Qiang Li, Na Li, Weiwei Tian, Jie Zhao, Guangzhong Yang, Yanping Ma, Xiaoqi Qin, Jing Jia, Huixing Zhou, Lintao Bi, Chenchen Wang, Ying Sun, Xiantao Liu, Yuan Jian, Qingming Wang, Haixiang Wan, Jinqiao Zhang, Han Liu, Hui Geng, Xiaojing Ma, Yunxia Liang, Rui Hu, Da Gao, Donghai Han, Haisheng Liu, Guangyu Ma, Zhihua Zhang, Wei Wang, Shi Minxia, Bo Nie, Zhang Hong, Jie Li, Guitao Jie, Meiying Fan, Qinglin Song, Wenyong Li, Zhenfang Xi, Guorong Gao, Jie Liu, Zhihua Li, Hua Xue, Huimei Guo, Jie Li, Xiaohan Gao, Guo-Hong Su, Jie Shen, ARong Jin, Peng Lv, Wenming Chen, Juan Li, Juan Du, Wen Gao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6925.
https://doi.org/10.1182/blood-2024-205155
Published: 2024
Journal Articles

Comparative Effectiveness of Linvoseltamab Versus Current Real-World (RW) Standard-of-Care (SOC) Therapies in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM): Key Subgroups Analysis

Free
Shaji Kumar, Sundar Jagannath, Katja C. Weisel, Laura Rosiñol Dachs, Meletios-Athanasios Dimopoulos, David S. Siegel, Jorge Monge, Xavier Leleu, Juan Du, Javier de la Rubia, Jae Hoon Lee, María-Victoria Mateos, Borja Puertas Martínez, Alessandro Gozzetti, Dominik Dytfeld, Enrique M. Ocio, Joan Bladé, Shuji Ozaki, Meral Beksac, Fernando Escalante, Madhu Nagaraj, Rafla Hassan, Paul Spin, Nicolle Bonar, Mostafa Shokoohi, Muhaimen Siddiqui, Di Wang, Kevin Hou, Jeannette Green, Olivier Humblet, Alexander Breskin, James Harnett, Wenzhen Ge, Rachel E. Sobel, Jessica J. Jalbert, Glenn S. Kroog, Karen Rodriguez Lorenc, Qiufei Ma, Christian Hampp, Brian G.M. Durie
Journal: Blood
Blood (2024) 144 (Supplement 1): 7012.
https://doi.org/10.1182/blood-2024-200679
Published: 2024
Journal Articles

Updated Results of a Phase I Open-Label Single-Arm Study of Dual Targeting BCMA and CD19 Fastcar-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Free
Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wenling Li, Wei Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1022.
https://doi.org/10.1182/blood-2023-174841
Published: 2023
Journal Articles

Identification of LPAR1/LPAR5 As Novel GPCR Partners of GPRC5D for the Efficient CAR-T Therapy of Multiple Myeloma

Free
Xinyi Zhou, Ying Yang, Xiaoli Hu, Tiancheng Luo, Shangrun Liu, Chao Zhang, Juan Du
Journal: Blood
Blood (2023) 142 (Supplement 1): 4679.
https://doi.org/10.1182/blood-2023-186150
Published: 2023
Journal Articles

Zanubrutinib Combined with R-CHOP in Previously Untreated Non-Germinal Center B-Cell (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) Patients with BCL2 and MYC Protein Co-Expression: A Multicenter, Phase II Study

Free
Jia Jin, Yalan Wang, Xi Wang, Yonghong Tang, Shan Zeng, Juan Du, Junning Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4468.
https://doi.org/10.1182/blood-2023-181529
Published: 2023
Journal Articles

PET Tracer-Based Glucose Uptake Predicts Clinical Response to Induction Therapy in Acute Myeloid Leukaemia

Free
Hui Zeng, Suqi Deng, Juan Du, Huien Zhan, Kexiu Huang, Xue Zheng, Ying Xu, Lu Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1592.
https://doi.org/10.1182/blood-2023-189148
Published: 2023
Journal Articles

Ixazomib Maintenance Therapy in Chinese Patients with Newly Diagnosed Multiple Myeloma Not Treated with Stem Cell Transplantation: A Single-Arm, Open-Label Study

Free
Weijun Fu, Juan Du, Lu Zhong, Lijuan Chen, Jian Li, Donghua Zhang, Jianqing Mi, Yan Liu, Sheng Wu, Richard Labotka, Cong Li, Wenhan Jiang, Wenming Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6735.
https://doi.org/10.1182/blood-2023-181444
Published: 2023
Journal Articles

Hexamethylene Amiloride Sensitizes AML to Venetoclax through Inducing Lysosomal Membrane Permeabilization

Free
Hui Zeng, Xinya Jiang, Juan Du, Lei Hua, Xiaofan Sun, Fangshu Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 8797–8798.
https://doi.org/10.1182/blood-2022-164960
Published: 2022
Journal Articles

Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes

Free
Ying Yu, Wenjie Xiong, Zanzan Wang, Yuting Yan, Jiawen Chen, Yanshan Huang, Xinxin Cao, Zhongxing Jiang, Huihan Wang, Zhen Cai, Juan Du, Chunyan Sun, Ting Niu, Guangzhong Yang, Hua Xue, Bingzong Li, Honghui Huang, Zhenling Li, Qinhua Liu, Fei Li, Ou Bai, Min Mao, Rong Fu, Ling Wang, Chunrui Li, Xiaoxia Chu, Lihong Liu, Yujun Dong, Luqun Wang, Jun Luo, Yongqiang Wei, Lugui Qiu, Jian Li, ShuHua Yi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9289–9291.
https://doi.org/10.1182/blood-2022-157311
Published: 2022